1. Home
  2. First Aid Supplies
  3. ECOTEST 15-Minute Rapid COVID-19 Antibody Test Kit
ECOTEST 15-Minute Rapid COVID-19 Antibody Test Kit
ECOTEST 15-Minute Rapid COVID-19 Antibody Test Kit

ECOTEST 15-Minute Rapid COVID-19 Antibody Test Kit

Your Price: $99,999.99
Part Number: 1128
Availability: Back Order.

***CALL FOR PRICING. IN STOCK AND SHIPS NEXT DAY FROM 02664. MUST BE PHYSICIAN, EMS, or HAVE LAB OVERSIGHT. FDA PROHIBITS SALE TO PRIVATE PARTIES***

The EcoTest COVID-19 IgG/IgM Rapid Test Device is an in-vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum or plasma.

EcoTest has been validated by the FDA and found to have a 100% Sensitivity for IgM (30/30) and 98.8% Specificity for IgM (79/80). IgG Sensitivity was 90% (27/30) and Specificity was 100% (80/80).

EcoTest is one of only a small number of COVID-19 rapid antibody tests that have both FDA Emergency Use Authorization and that detect two types of antibodies (IgM and IgG) - IgM peaks early in the disease and IgG peaks later during the illness. This combination provides broader capture of patients exposed to COVID-19. EcoTest performance was validated by a US physician researcher and several of the box contents were enhanced as a result. There is no other COVID Rapid Antibody test like it on the market. EcoTest is for professional use only.


Features & Benefits

  • Results in 15 minutes

  • Easy to use and read

  • Tests for both IgM and IgG antibodies

  • Individually packaged kits for one time use

  • Validated against RT-PCR results

Important Information

  • This test has been authorized by FDA under an EUA for use by authorized laboratories (see documentation tab).

  • This test has not been FDA cleared or approved.

  • This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens.

  • This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

  • Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.

  • This product is intended for professional use and not for home use.

  • This product is not for the screening of donated blood.



The data shown below is from testing performed on 2020-06-10 at the Frederick National Laboratory for Cancer Research (FNLCR), a Federally Funded Research and Development Center (FFRDC) sponsored by the National Cancer Institute (NCI).

Screen Shot 2020-07-29 at 12.24.18 PM.png

Screen Shot 2020-08-04 at 2.36.33 PM.png

Related Items